Approval · Notice of Compliance 8115 · 2006
APO-RISPERIDONE: Notice of Compliance 8115
Issued July 5, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8115
- Date
- July 5, 2006
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Antispychotic agent
- Canadian reference product
- RISPERDAL ORAL SOLUTION (Janssen-Ortho Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APO-RISPERIDONE | 02280396 | Dormant |
Medicinal ingredients
- RISPERIDONE TARTRATE 1 MG per ML